Drug Type Small molecule drug |
Synonyms PSMA 1092 |
Target |
Action modulators |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC50H62N12O16S2 |
InChIKeyBJKPHQIRJVRGKT-CUPIEXAXSA-N |
CAS Registry2481214-35-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Discovery | China | 10 Jun 2021 |